Arc-1 Tirzepatide Review: Dose Prices and Return Limits

Arc-1's compounded tirzepatide product has conflicting starting prices. Its heading says starting at $149 per month, while the product listing starts at $199.99 and its named dose options associate $199.99 with 2.5 mg, $249.99 with 5 mg and $399.99 with 7.5 mg. Those labels do not by themselves establish the quantity supplied, duration or a patient's approved total.^3,4

Confirm the dose, quantity and payment period

The older $299.99 entry-price description should not be treated as the current starting quote. The current public product also describes a tirzepatide, glycine and B12 preparation. A product description is not a prescription: ask the clinician to confirm the actual formulation, concentration, prescribed dose, vial quantity and usable supply period before comparing costs.³

Do not turn a dose label into a vial concentration, a month of medication or a dosing instruction. The product's availability messages also need confirmation for the chosen option. Obtain the current amount due, required consultation and laboratory costs, shipping and the refill price in one written quote. The $149 headline and the higher named options do not establish one introductory-and-renewal schedule.^3,4

The product page describes checkout before the medical intake and provider review; the separate process page emphasizes treatment selection, intake, review and approval before order processing. Ask when payment is authorized or captured and what happens if the clinician declines the treatment or changes the prescription. Neither description establishes a universal automatic-refill arrangement.^3,5

A satisfaction headline is not a medication refund promise

The public return policy allows requests within thirty days of receiving an eligible item, requiring it to be unused, in original packaging and supported by proof of purchase. It excludes custom or personalized products, perishable goods and sale items. A prescription preparation may raise different conditions from an ordinary retail purchase; obtain the rule applicable to your medication before paying.⁶

The policy says approved refunds return to the original payment method within six to eight weeks, with bank posting potentially taking additional time. It asks patients to report damage, defects or a wrong item immediately. It does not clearly explain a medical-nonapproval refund, the point when prescription cancellation becomes impossible or a remedy for an unused compounded vial. The thirty-day satisfaction message should not be read as an unconditional medication money-back guarantee.^3,6

Check service eligibility and the dispensing facility

The product page excludes California, Arkansas, Indiana, Minnesota and South Carolina. Confirm your physical location and the treating clinician's availability; a public service list is not independent current licensure verification. Arc-1 describes licensed third-party pharmacies, but that does not establish your actual preparing or dispensing facility.³

Compounded medication is not FDA-approved. Broad approval or brand-equivalence language elsewhere on the site does not change that status or establish equivalent outcomes for this preparation. The original brand-drug trials do not validate Arc-1's product or patients.^1,2,3 Confirm the selected offer and accepted prescription, cancellation and payment agreement before proceeding.

Further reading

whether compounded tirzepatide is still legal in 2026, Zepbound side effects, the gallbladder risk, thyroid cancer warning, tirzepatide evidence guide, bmiMD, best tirzepatide providers.